Skip to main content
. 2020 Mar 25;25(7):1497. doi: 10.3390/molecules25071497

Figure 6.

Figure 6

Comparison of cytotoxic activity of selected CK2-HDAC dual inhibitors (7c, 11b, 11c, 11d, 15a and 19) towards human leukemia (top left), carcinoma (top right and down left,) and pseudonormal (down right) cell lines. Trypan blue assay, 24 h incubation. Means and SD of at least three experiments in triplicate are shown.